reamberin and Bacteremia

reamberin has been researched along with Bacteremia* in 1 studies

Other Studies

1 other study(ies) available for reamberin and Bacteremia

Article	Year
[Increase of antibacterial therapy efficacy in chronic sepsis with cycloferon and reamberin combination]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2012, Volume: 57, Issue:5-6 The use of reamberin and cycloferon combination for increasing the antibacterial therapy efficacy in patients with chronic sepsis (CS) was studied. It was shown that the combination provided more rapid elimination of the CS exacerbation symptoms, normalization of the hematologic indices, bacteriemia eradication and reduction of the cytokine blood profile--normal serum levels of proinflammatory (IL-1beta, IL-2, IL-6 and TNF-alpha) and antiinflammatory (IL-4) cytokines. The findings allowed to considered the use of the reamberin and cycloferon combination in the treatment of patients with CS pathogenetically reasonable and clinically perspective for increasing the antibacterial therapy efficacy. Topics: Acridines; Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Cytokines; Drug Therapy, Combination; Female; Humans; Interferon Inducers; Interleukin-1beta; Interleukin-2; Interleukin-4; Interleukin-6; Male; Meglumine; Middle Aged; Sepsis; Streptococcus pyogenes; Succinates; Tumor Necrosis Factor-alpha	2012

Article

Year

[Increase of antibacterial therapy efficacy in chronic sepsis with cycloferon and reamberin combination].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2012, Volume: 57, Issue:5-6

The use of reamberin and cycloferon combination for increasing the antibacterial therapy efficacy in patients with chronic sepsis (CS) was studied. It was shown that the combination provided more rapid elimination of the CS exacerbation symptoms, normalization of the hematologic indices, bacteriemia eradication and reduction of the cytokine blood profile--normal serum levels of proinflammatory (IL-1beta, IL-2, IL-6 and TNF-alpha) and antiinflammatory (IL-4) cytokines. The findings allowed to considered the use of the reamberin and cycloferon combination in the treatment of patients with CS pathogenetically reasonable and clinically perspective for increasing the antibacterial therapy efficacy.

Topics: Acridines; Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Cytokines; Drug Therapy, Combination; Female; Humans; Interferon Inducers; Interleukin-1beta; Interleukin-2; Interleukin-4; Interleukin-6; Male; Meglumine; Middle Aged; Sepsis; Streptococcus pyogenes; Succinates; Tumor Necrosis Factor-alpha

2012